This week's View focuses on the coronavirus disease 2019 (COVID-19) resources on ACC.org, including key points from a review of studies addressing the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an article on the clinical utility of antibody testing for SARS-CoV-2, and a trial evaluating hydroxychloroquine compared with placebo among nonhospitalized patients with confirmed or probable COVID-19 infection.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Cardiovascular Care Team, COVID-19 Hub, Heart Failure and Cardiomyopathies, Prevention, Novel Agents, Statins, Acute Heart Failure

Keywords: EaglesEyeView, Coronavirus, Coronavirus Infections, severe acute respiratory syndrome coronavirus 2, COVID-19, ACC COVID-19 Podcast, Angiotensin-Converting Enzyme Inhibitors, Antibody Specificity, Antigens, Viral, Cross Protection, Hospitalization, Hydroxychloroquine, Immunity, Humoral, Immunoglobulin G, Interferon Type I, Kinetics, Membrane Glycoproteins, Peptidyl-Dipeptidase A, Polymerase Chain Reaction, Primary Prevention, Receptors, IgG, RNA, Messenger, Spike Glycoprotein, Coronavirus, Th1 Cells, Vaccine Potency, Heart Failure

< Back to Listings